These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The role of changes in the antioxidative activity and phospholipid composition of the rat liver in the mechanism of phenazepam action on the liver and the protective effect of talamonal]. Molochkina EM, Kaipova GD, Papin AA, Korotkina RN, Karelin AA. Vopr Med Khim; 1985; 31(3):17-21. PubMed ID: 4024526 [Abstract] [Full Text] [Related]
10. [Biotransformation of the 14C-hydrogenated analog of phenazepam in inbred mice]. Sozinov VA, Seredenin SB, Golovenko NIa. Biull Eksp Biol Med; 1987 May; 103(5):581-3. PubMed ID: 3593933 [Abstract] [Full Text] [Related]
12. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Donato MT, Castell JV, Gómez-Lechón MJ. Drug Metab Dispos; 1995 May; 23(5):553-8. PubMed ID: 7587930 [Abstract] [Full Text] [Related]
13. Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization. Blouin RA, Bandyopadhyay AM, Chaudhary I, Robertson LW, Gemzik B, Parkinson A. Arch Biochem Biophys; 1993 Jun; 303(2):313-20. PubMed ID: 8512318 [Abstract] [Full Text] [Related]
18. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH, Mannering GJ. Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917 [Abstract] [Full Text] [Related]